Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
Clinical trial NCT05636267 · TERMINATED
Trial details
- NCT number
- NCT05636267
- Sponsor
- Akeso
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2025-02-24
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.